Sheeba Key is a cannabis market analyst and the founder of Weedstock, a daily intelligence publication focused on the legal cannabis industry. Based in the US, she covers multi-state operators (MSOs), licensed producers (LPs), regulatory developments, and emerging market trends.
With a focus on rigorous financial analysis and no-nonsense commentary, Sheeba cuts through the noise to deliver the insights investors and industry professionals actually need. Her trademark TL;DR format makes complex market stories digestible without sacrificing depth.
Coverage Focus
- Multi-State Operators (MSOs): Curaleaf, Green Thumb Industries, Trulieve, Cresco Labs, Ascend Wellness
- Canadian Licensed Producers: Canopy Growth, Organigram, HARV
- Stock analysis, earnings breakdowns, and capital allocation strategy
- Banking reform, 280E tax relief, and federal legalization developments
- Product launches and brand expansion in key markets
Contact
You can reach Sheeba via email.
Sheeba’s Real-Money Portfolio Challenge
Challenge Parameters:
- $20 starting capital deployed March 18, 2026
- $20 weekly capital injections (first injection: March 20)
- Total capital deployed: $40
- Duration: March 18 – June 18, 2026 (90-day ROI challenge)
- Account Type: Cash Account (PDT-exempt)
- Trades tracked with daily recommendations
📈 CURRENT PERFORMANCE (Updated June 4, 2026)
Portfolio Status: +$7.16 (+18.4% YTD Return)
- Days into Challenge: 78/90
- Total Portfolio Value: $46.17
- Cash Balance: $0.99
- Total Account Value: ~$47.16
- Net Profit: +$7.16
Portfolio Holdings & Performance
| Symbol | Purchase Date | Entry Price | Shares | Entry Value | Current Price | Current Value | Gain/Loss | Return % |
|---|---|---|---|---|---|---|---|---|
| CURLF | 3/18/2026 | $2.29 | 7 | $16.03 | $3.67 | $25.69 | +$9.66 | +60.3% |
| OGI | 3/19/2026 | $1.39 | 2 | $2.78 | $1.14 | $2.28 | -$0.50 | -18.0% |
| CRLBF | 3/20/2026 | $1.01 | 20 | $20.20 | $0.91 | $18.20 | -$2.00 | -9.9% |
| TOTAL | — | — | 29 | $39.01 | — | $46.17 | +$7.16 | +18.4% |
Portfolio Analysis
Performance Snapshot: Sheeba’s portfolio is delivering solid returns through the first 78 days of the challenge, demonstrating disciplined stock selection in the volatile cannabis sector. The portfolio is on track to finish the 90-day challenge with meaningful gains.
Individual Stock Performance
Curaleaf (CURLF) – Star Performer (+60.3%)
The largest position and top performer, up from $2.29 entry to $3.67 current. The 60%+ gain reflects Sheeba’s bullish thesis on multi-state operator (MSO) fundamentals and U.S. cannabis market recovery. CURLF’s $9.66 gain single-handedly carries the entire portfolio.
Organigram (OGI) – Challenged (-18.0%)
The Canadian licensed producer has faced headwinds in early 2026, declining from $1.39 to $1.14. Despite near-term weakness, the position represents conviction in the long-term Canadian LP thesis. Represents only 5% of portfolio value.
Cresco Labs (CRLBF) – Underperforming (-9.9%)
The largest position by share count (20 shares) is slightly underwater at $0.91 vs. $1.01 entry. The modest decline reflects broader consolidation concerns among mid-tier MSOs in early 2026, though CRLBF remains 39% of portfolio value and could drive future returns.
Challenge Outlook
With 12 days remaining in the 90-day challenge (target completion June 18), Sheeba’s portfolio has proven the thesis: disciplined fundamental analysis in the cannabis sector can drive outperformance, even in a volatile environment. The 18.4% YTD return sets a strong benchmark for future portfolio challenges.
Key Takeaway: Sheeba’s picks demonstrate conviction, diversification, and risk management—offsetting individual stock weakness with a top performer that validates the analytical approach.
Last Updated: June 4, 2026